北京阿迈特医疗器械有限公司

您当前的位置: 新闻动态

【学术论文】 Six-month outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in treating single de novo lesions in human coronary artery

2016-08-12
【行业资讯】科学家称五年内将3D打印人类心脏

2016-06-24
【公司新闻】阿迈特专家委员会成立

2016-06-01
【行业资讯】中国心脏支架产业发展报告

2015-08-27
【学术论文】 Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds: Evidence From a Network Meta-Analysis of 147 Trials.

2015-08-04
【学术论文】 Outcomes with bioabsorbable vascular scaffolds versus everolimus-eluting stents Insights from randomized trials

2015-08-04
【学术论文】 Everolimus-eluting bioresorbable vascular scaff olds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled

2015-08-04
【学术论文】 A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimuseluting metallic stents in patients with coronary artery disease: ABSORB Japan

2015-08-03
【公司新闻】首届中国创新成果交流会在广州举办

2015-05-26
【公司新闻】 3D打印：还会给你更多惊喜

2014-09-02

首页 <上一页 1 2 3 4 5 6 7 8 下一页> 尾页